Newport Pharmaceuticals International, Inc. Laboratory of North American origin founded in 1968. In 1993 it was renamed SysteMed, Inc.; in order to reflect with greater clarity the main activity that developed in the North American market. Newport Pharmaceuticals of Costa Rica, was founded on 1970 in order to take care of the pharmaceutical markets of Latin America and Asia. It has vast experience in international transactions.

The creation of an international network of distributors and licensees facilitates the development of the company and constitutes one of the most appraised assets.

The primary interest of Newport Pharmaceuticals is products for the treatment of infectious diseases, immunological disorders and related conditions.

The present core of Newport Pharmaceuticals is the identification of pharmaceutical opportunities and to heighten the drugs´s value with a process of innovation and transformation.